Skip to main content
MedicineWatch US
Explore records
Trends
Coverage
About
Methodology
Report an issue
Privacy
SCOPE HEALTH
Provisional
New York, NY · united states
1 recall flag(s)
FDA Flags (1)
Class II Recall
May 2026
SCOPE HEALTH
Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Ma
Classification: Class II